1-5 of 5
Devora Delman
Close
Save search
Sort by
Journal Articles

Alvocidib Potentiates the Activity of Venetoclax in Preclinical Models of Acute Myeloid Leukemia

Free
Clifford J. Whatcott, PhD, James M Bogenberger, PhD, Wontak Kim, Hillary Haws, Nanna Hansen, M.S., Devora Delman, B.S., Lisa Sproat, MD MSW, Jeanne Palmer, MD, Ruben A. Mesa, MD, Peter Peterson, PhD, Adam Siddiqui-Jain, PhD, Steven Weitman, MD PhD, David J. Bearss, PhD, Steven L. Warner, PhD, Raoul Tibes, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1652.
https://doi.org/10.1182/blood.V128.22.1652.1652
Published: 2016
Journal Articles

Synergistic Activity of Lysine Deacetylase Inhibitors and Microtubule-Targeting Agents in AML

Free
James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Lisa Sproat, MD MSW, Jeanne Palmer, MD, Ruben Mesa, MD FACP, Raoul Tibes, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3948.
https://doi.org/10.1182/blood.V128.22.3948.3948
Published: 2016
Journal Articles

Identification and Mechanistic Characterization of CMPD1 As a Selective Sensitizer of Histone Deacetylase Inhibitors in Myeloid Malignancies

Free
James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Ruben A. Mesa, Raoul Tibes, MD
Journal: Blood
Blood (2015) 126 (23): 3689.
https://doi.org/10.1182/blood.V126.23.3689.3689
Published: 2015
Journal Articles

MK2a Substrate-Selective p38 Inhibitor CMPD1 Selectively Synergizes with HDAC Inhibitors in CD34 + Cells from Myeloid Malignancies

Free
James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Ruben A. Mesa, MD, Raoul Tibes, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2239.
https://doi.org/10.1182/blood.V124.21.2239.2239
Published: 2014
Journal Articles

The Hedgehog Pathway As Targetable Vulnerability with 5-Azacitidine in MDS and AML

Free
Raoul Tibes, MD PhD, Devora Delman, B.S., Nanna Hansen, M.S., Krisstina L. Gowin, DO, Ruben Mesa, MD, James M Bogenberger, PhD
Journal: Blood
Blood (2014) 124 (21): 4612.
https://doi.org/10.1182/blood.V124.21.4612.4612
Published: 2014